Market Value1,714,347,327
Total Holdings49
File Date2023-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
AXNX / Axonics, Inc.
AVIR / Atea Pharmaceuticals, Inc.
US39536G1058 / GREENLIGHT BIOSCIENCES HOLDINGS PBC A
AKRO / Akero Therapeutics, Inc.
BCEL / Atreca, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
ZNTL / Zentalis Pharmaceuticals, Inc.
OCUL / Ocular Therapeutix, Inc.
MLTX / MoonLake Immunotherapeutics
LPTX / Leap Therapeutics, Inc.
VERV / Verve Therapeutics, Inc.
APLS / Apellis Pharmaceuticals, Inc. Call
IRON / Disc Medicine, Inc.
CABA / Cabaletta Bio, Inc.
STOK / Stoke Therapeutics, Inc.
PHVS / Pharvaris N.V.
INSM / Insmed Incorporated
ELVN / Enliven Therapeutics, Inc.
PRAX / Praxis Precision Medicines, Inc.
ACLX / Arcellx, Inc.
RNA / Avidity Biosciences, Inc.
TARS / Tarsus Pharmaceuticals, Inc.
DSGN / Design Therapeutics, Inc.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
COGT / Cogent Biosciences, Inc.
HARP / Harpoon Therapeutics, Inc.
IMRX / Immuneering Corporation
ALXO / ALX Oncology Holdings Inc.
PCVX / Vaxcyte, Inc.
VIGL / Vigil Neuroscience, Inc.
RAPT / RAPT Therapeutics, Inc.
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
BMEA / Biomea Fusion, Inc.
EWTX / Edgewise Therapeutics, Inc.
AXSM / Axsome Therapeutics, Inc.
GHRS / GH Research PLC
BBIO / BridgeBio Pharma, Inc.
BBIO / BridgeBio Pharma, Inc. Put
SRPT / Sarepta Therapeutics, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
BCAB / BioAtla, Inc.
LIANY / LianBio - Depositary Receipt (Common Stock)
MORF / Morphic Holding, Inc.
ETNB / 89bio, Inc.
VRDN / Viridian Therapeutics, Inc.
GLTO / Galecto, Inc.
PTGX / Protagonist Therapeutics, Inc.
ATXS / Astria Therapeutics, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
GRPH / Graphite Bio, Inc.
IMVT / Immunovant, Inc.
ERAS / Erasca, Inc.
ISEE / IVERIC bio Inc Call
CBAY / CymaBay Therapeutics, Inc.
AVTE / Aerovate Therapeutics, Inc.
LBPH / Longboard Pharmaceuticals, Inc.
NMRA / Neumora Therapeutics, Inc.
HARP / Harpoon Therapeutics, Inc.
KRTX / Karuna Therapeutics, Inc.
BHVN / Biohaven Ltd.
RYZB / RayzeBio, Inc.
ALPN / Alpine Immune Sciences, Inc.
IDYA / IDEAYA Biosciences, Inc.
ARQT / Arcutis Biotherapeutics, Inc.
MRNS / Marinus Pharmaceuticals, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
AMAM / Ambrx Biopharma Inc.
OLMA / Olema Pharmaceuticals, Inc.
APLS / Apellis Pharmaceuticals, Inc.
EYPT / EyePoint Pharmaceuticals, Inc.